Sienna Formulations Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.20 M
- Company Age 21 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -72.78%
- Profit Growth 54.93%
- Ebitda 55.13%
- Net Worth -7.71%
- Total Assets -56.32%
About Sienna Formulations
Sienna Formulations Private Limited (SFPL) is a Private Limited Indian Non-Government Company incorporated in India on 17 September 2003 and has a history of 21 years and four months. Its registered office is in Mumbai, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.20 M, as per Ministry of Corporate Affairs (MCA) records.
Ashokkumar Jain and Pravin Jain serve as directors at the Company.
Company Details
-
Location
Mumbai, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24231MH2003PTC369600
-
Company No.
042925
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
17 Sep 2003
-
Date of AGM
12 Jul 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Sienna Formulations?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Ashokkumar Jain
|
Director | 30-Mar-2013 | Current |
|
Pravin Jain
|
Director | 11-Feb-2009 | Current |
Financial Performance of Sienna Formulations.
Sienna Formulations Private Limited, for the financial year ended 2016, experienced significant reduction in revenue, with a 72.78% decrease. The company also saw a substantial improvement in profitability, with a 54.93% increase in profit. The company's net worth dipped by a decrease of 7.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sienna Formulations?
In 2017, Sienna Formulations had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Uttaranchal Biotech LimitedPravin Jain is a mutual person
-
Surajlok Chemicals Private LimitedAshokkumar Jain and Pravin Jain are mutual person
-
Neon Laboratories LimitedAshokkumar Jain and Pravin Jain are mutual person
-
Korten Pharmaceuticals Private LimitedPravin Jain is a mutual person
-
Axiommax Oncology Private LimitedAshokkumar Jain is a mutual person
-
Vhb Pharmaceuticals Private LimitedAshokkumar Jain and Pravin Jain are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Sienna Formulations?
Unlock and access historical data on people associated with Sienna Formulations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sienna Formulations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sienna Formulations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
